| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 146, Issue 10 3523-3527, Copyright © 1991 by American Association of Immunologists
ARTICLES |
WY Almawi, ML Lipman, AC Stevens, B Zanker, ET Hadro and TB Strom
Department of Medicine, Harvard Medical School, Boston, MA.
Glucocorticoids (GCS) inhibit the transcription of multiple activation- associated cytokine genes. By Northern blot analysis now we demonstrate that antiproliferative concentrations of dexamethasone and 6 alpha- methylprednisolone block mitogen-induced IL-2 gene expression in human peripheral blood mononuclear leukocytes in a concentration-dependent fashion. In addition, using a mitogen-induced proliferation assay of human peripheral blood mononuclear leukocytes, we show that GCS- mediated anti-proliferative effects are not blocked by rIL-1, rIL-2, rIL-3, rIL-4, rIL-5, rIL-6, rTNF-alpha, rTNF-beta, and rIFN-gamma, individually at 1 to 1000 U/ml, but are totally abrogated, in a concentration-dependent fashion, by the combination of rIL-1, rIL-6, and rIFN-gamma (25 to 50 U/ml for each cytokine). Thus, blockade of cytokine expression is the primary mechanism by which GCS inhibit mitogen-driven and alloantigen-induced T cell proliferation. The immunosuppressive effects of GCS are almost certainly exacted at the level of cytokine gene transcription.
This article has been cited by other articles:
|
|
 |
|
  E. Roggero, A. R Perez, M. Tamae-Kakazu, I. Piazzon, I. Nepomnaschy, H. O Besedovsky, O. A Bottasso, and A. del Rey Endogenous glucocorticoids cause thymus atrophy but are protective during acute Trypanosoma cruzi infection. J. Endocrinol., August 1, 2006; 190(2): 495 - 503. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Tliba, J. A. Cidlowski, and Y. Amrani CD38 Expression Is Insensitive to Steroid Action in Cells Treated with Tumor Necrosis Factor-{alpha} and Interferon-{gamma} by a Mechanism Involving the Up-Regulation of the Glucocorticoid Receptor beta Isoform Mol. Pharmacol., February 1, 2006; 69(2): 588 - 596. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. C. Chikanza and D. L. Kozaci Corticosteroid resistance in rheumatoid arthritis: molecular and cellular perspectives Rheumatology, November 1, 2004; 43(11): 1337 - 1345. [Full Text] [PDF]
|
|
|
|
 |
|
 G U. MEDURI and C. R. YATES Systemic Inflammation-Associated Glucocorticoid Resistance and Outcome of ARDS Ann. N.Y. Acad. Sci., June 1, 2004; 1024(1): 24 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.U. Meduri, P. Carratu, and A.X. Freire Evidence of biological efficacy for prolonged glucocorticoid treatment in patients with unresolving ARDS Eur. Respir. J., August 1, 2003; 22(42_suppl): 57s - 64s. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. U. Meduri, E. A. Tolley, G. P. Chrousos, and F. Stentz Prolonged Methylprednisolone Treatment Suppresses Systemic Inflammation in Patients with Unresolving Acute Respiratory Distress Syndrome . Evidence for Inadequate Endogenous Glucocorticoid Secretion and Inflammation-induced Immune Cell Resistance to Glucocorticoids Am. J. Respir. Crit. Care Med., April 1, 2002; 165(7): 983 - 991. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Y. Almawi and O. K. Melemedjian Molecular mechanisms of glucocorticoid antiproliferative effects: antagonism of transcription factor activity by glucocorticoid receptor J. Leukoc. Biol., January 1, 2002; 71(1): 9 - 15. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. JANTZ and S. A. SAHN Corticosteroids in Acute Respiratory Failure Am. J. Respir. Crit. Care Med., October 1, 1999; 160(4): 1079 - 1100. [Full Text]
|
|
|
|
 |
|
 J. D. Milner, S. C. Kent, T. A. Ashley, S. B. Wilson, J. L. Strominger, and D. A. Hafler Differential Responses of Invariant V{alpha}24J{alpha}Q T Cells and MHC Class II-Restricted CD4+ T Cells to Dexamethasone J. Immunol., September 1, 1999; 163(5): 2522 - 2529. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Harley, C. R. Helps, D. A. Harbour, T. J. Gruffydd-Jones, and M. J. Day Cytokine mRNA Expression in Lesions in Cats with Chronic Gingivostomatitis Clin. Vaccine Immunol., July 1, 1999; 6(4): 471 - 478. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-F. Weng, W. Zhao, K. V. Fegeding, J. L. Komisar, and J. Tseng Resistance of staphylococcal enterotoxin B- induced proliferation and apoptosis to the effects of dexamethasone in mouse lymphocyte cultures Int. Immunol., May 1, 1999; 11(5): 787 - 801. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ramdas and J. M. Harmon Glucocorticoid-Induced Apoptosis and Regulation of NF-{kappa}B Activity in Human Leukemic T Cells Endocrinology, September 1, 1998; 139(9): 3813 - 3821. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Ray and S. Melmed Pituitary Cytokine and Growth Factor Expression and Action Endocr. Rev., April 1, 1997; 18(2): 206 - 228. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. P. Chrousos The Hypothalamic-Pituitary-Adrenal Axis and Immune-Mediated Inflammation N. Engl. J. Med., May 18, 1995; 332(20): 1351 - 1363. [Full Text] [PDF]
|
|
|
|
|
|
M. Suthanthiran and T. B. Strom Renal Transplantation N. Engl. J. Med., August 11, 1994; 331(6): 365 - 376. [Full Text]
|
|
|
|
 |
|
 S Chettibi, A. Lawrence, J. Young, P. Lawrence, and R. Stevenson Dispersive locomotion of human neutrophils in response to a steroid-induced factor from monocytes J. Cell Sci., January 11, 1994; 107(11): 3173 - 3181. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
